查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1475162

全球体内 CRO 市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global In Vivo CRO Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 222 Pages | 商品交期: 最快1-2个工作天内

价格

全球体内 CRO 市场需求预计将从 2023 年的 50.6 亿美元达到近 101.9 亿美元的市场规模，2024 年至 2032 年研究期间复合年增长率为 8.09%。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球 in vivo cro 市场的各个细分市场进行了包容性评估。体内微生物产业的成长和趋势为本研究提供了整体方法。

市场区隔

in vivo cro 市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按动物模型分类

  • 基于囓齿动物（大鼠模型、小鼠模型、其他囓齿动物模型）
  • 不囓齿类动物

按服务

  • 生物分析和 Dmpk 研究
  • 毒性研究（Glp 毒理学研究、非 Glp 毒理学研究）
  • 其他服务

依药物类型

  • 小分子药物
  • 大分子药物（细胞和基因治疗、RNA治疗、其他）

按治疗领域

  • 肿瘤学
  • 临床药理学
  • 心臟病学
  • 传染性疾病
  • 神经病学
  • 胃肠病学和肝病学
  • 代谢与内分泌
  • 眼科
  • 自体免疫性/发炎性疾病
  • 其他

按最终用途

  • 製药及生物製药公司
  • 医疗器材公司
  • 学术及研究机构

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲体内 CRO 市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。体内 CRO 市场的主要参与者包括 Biocytogen、Charles River Laboratories International Inc.、Crown Bioscience、Evotec、GemPharmatech、IQVIA Inc.、Icon Plc、Labcorp Drug Development、Parexel International Corporation、PsychoGenics Inc.、Taconic Biosciences, Inc.。节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：体内 CRO - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 动物模型的市场吸引力分析
    • 按服务分類的市场吸引力分析
    • 按药物类型分類的市场吸引力分析
    • 按治疗领域分類的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球体内 CRO 市场分析：按动物模型

  • 按动物模型概述
  • 历史和预测数据
  • 动物模型分析
  • 基于囓齿动物（大鼠模型、小鼠模型、其他囓齿动物模型）
  • 不囓齿类动物

第 6 章：全球体内 CRO 市场分析：依服务分类

  • 按服务概览
  • 历史和预测数据
  • 按服务分析
  • 生物分析和 DMPK 研究
  • 毒性研究（GLP 毒理学研究、非 GLP 毒理学研究）
  • 其他服务

第 7 章：全球体内 CRO 市场分析：依药物类型

  • 按药物类型概述
  • 历史和预测数据
  • 依药物类型分析
  • 小分子药物
  • 大分子药物（细胞和基因治疗、RNA治疗、其他）

第 8 章：全球体内 CRO 市场分析：依治疗领域

  • 按治疗领域概述
  • 历史和预测数据
  • 按治疗领域分析
  • 肿瘤学
  • 临床药理学
  • 心臟病学
  • 传染性疾病
  • 神经病学
  • 胃肠病学和肝病学
  • 代谢与内分泌
  • 眼科
  • 自体免疫性/发炎性疾病
  • 其他

第 9 章：全球体内 CRO 市场分析：依最终用途分类

  • 按最终用途分类的概述
  • 历史和预测数据
  • 按最终用途分析
  • 製药及生物製药公司
  • 医疗器材公司
  • 学术及研究机构

第 10 章：全球体内 CRO 市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 11 章：体内 CRO 公司的竞争格局

  • 体内CRO市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 12 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Biocytogen
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Charles River Laboratories International Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Crown Bioscience
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Evotec
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GemPharmatech
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • IQVIA Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Icon Plc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Labcorp Drug Development
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Parexel International Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • PsychoGenics Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Taconic Biosciences Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112114389

The global demand for In Vivo CRO Market is presumed to reach the market size of nearly USD 10.19 Billion by 2032 from USD 5.06 Billion in 2023 with a CAGR of 8.09% under the study period 2024 - 2032.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in vivo cro. The growth and trends of in vivo cro industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the in vivo cro market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Animal Model

  • Rodent-Based (Rat Models, Mice Models, Other Rodent Models)
  • Non-Rodent-Based

By Service

  • Bioanalysis & Dmpk Studies
  • Toxicity Studies (Glp Toxicology Studies, Non-Glp Toxicology Studies)
  • Other Services

By Drug Type

  • Small-Molecule Drugs
  • Large-Molecule Drugs (Cell & Gene Therapy, Rna Therapy, Other)

By Therapeutic Area

  • Oncology
  • Clinical Pharmacology
  • Cardiology
  • Infectious Diseases
  • Neurology
  • Gastroenterology & Hepatology
  • Metabolic & Endocrine
  • Ophthalmology
  • Autoimmune / Inflammatory Conditions
  • Other

By End-Use

  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the In Vivo CRO market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In Vivo CRO market include Biocytogen, Charles River Laboratories International Inc., Crown Bioscience, Evotec, GemPharmatech, IQVIA Inc., Icon Plc, Labcorp Drug Development, Parexel International Corporation, PsychoGenics Inc., Taconic Biosciences, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. IN VIVO CRO - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Animal Model
    • 3.7.2 Market Attractiveness Analysis By Service
    • 3.7.3 Market Attractiveness Analysis By Drug Type
    • 3.7.4 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL IN VIVO CRO MARKET ANALYSIS BY ANIMAL MODEL

  • 5.1. Overview By Animal Model
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Animal Model
  • 5.4. Rodent-Based (Rat Models, Mice Models, Other Rodent Models) Historic and Forecast Sales By Regions
  • 5.5. Non-Rodent-Based Historic and Forecast Sales By Regions

6. GLOBAL IN VIVO CRO MARKET ANALYSIS BY SERVICE

  • 6.1. Overview By Service
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Service
  • 6.4. Bioanalysis & DMPK Studies Historic and Forecast Sales By Regions
  • 6.5. Toxicity Studies (GLP Toxicology Studies, Non-GLP Toxicology Studies) Historic and Forecast Sales By Regions
  • 6.6. Other Services Historic and Forecast Sales By Regions

7. GLOBAL IN VIVO CRO MARKET ANALYSIS BY DRUG TYPE

  • 7.1. Overview By Drug Type
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Drug Type
  • 7.4. Small-Molecule Drugs Historic and Forecast Sales By Regions
  • 7.5. Large-Molecule Drugs (Cell & Gene Therapy, RNA Therapy, Other) Historic and Forecast Sales By Regions

8. GLOBAL IN VIVO CRO MARKET ANALYSIS BY THERAPEUTIC AREA

  • 8.1. Overview By Therapeutic Area
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Therapeutic Area
  • 8.4. Oncology Historic and Forecast Sales By Regions
  • 8.5. Clinical Pharmacology Historic and Forecast Sales By Regions
  • 8.6. Cardiology Historic and Forecast Sales By Regions
  • 8.7. Infectious Diseases Historic and Forecast Sales By Regions
  • 8.8. Neurology Historic and Forecast Sales By Regions
  • 8.9. Gastroenterology & Hepatology Historic and Forecast Sales By Regions
  • 8.10. Metabolic & Endocrine Historic and Forecast Sales By Regions
  • 8.11. Ophthalmology Historic and Forecast Sales By Regions
  • 8.12. Autoimmune / Inflammatory Conditions Historic and Forecast Sales By Regions
  • 8.13. Other Historic and Forecast Sales By Regions

9. GLOBAL IN VIVO CRO MARKET ANALYSIS BY END-USE

  • 9.1. Overview By End-use
  • 9.2. Historical and Forecast Data
  • 9.3. Analysis By End-use
  • 9.4. Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales By Regions
  • 9.5. Medical Device Companies Historic and Forecast Sales By Regions
  • 9.6. Academic & Research Institutes Historic and Forecast Sales By Regions

10. GLOBAL IN VIVO CRO MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE IN VIVO CRO COMPANIES

  • 11.1. In Vivo CRO Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF IN VIVO CRO INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Biocytogen
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Charles River Laboratories International Inc.
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Crown Bioscience
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. Evotec
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. GemPharmatech
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. IQVIA Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. Icon Plc
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Labcorp Drug Development
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Parexel International Corporation
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. PsychoGenics Inc.
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments
  • 12.13. Taconic Biosciences Inc.
    • 12.13.1 Company Overview
    • 12.13.2 Company Revenue
    • 12.13.3 Products
    • 12.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Animal Model (USD MN)
  • Rodent-Based (Rat Models, Mice Models, Other Rodent Models) Market Sales By Geography (USD MN)
  • Non-Rodent-Based Market Sales By Geography (USD MN)
  • Analysis By Service (USD MN)
  • Bioanalysis & DMPK Studies Market Sales By Geography (USD MN)
  • Toxicity Studies (GLP Toxicology Studies, Non-GLP Toxicology Studies) Market Sales By Geography (USD MN)
  • Other Services Market Sales By Geography (USD MN)
  • Analysis By Drug Type (USD MN)
  • Small-Molecule Drugs Market Sales By Geography (USD MN)
  • Large-Molecule Drugs (Cell & Gene Therapy, RNA Therapy, Other) Market Sales By Geography (USD MN)
  • Analysis By Therapeutic Area (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Clinical Pharmacology Market Sales By Geography (USD MN)
  • Cardiology Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Neurology Market Sales By Geography (USD MN)
  • Gastroenterology & Hepatology Market Sales By Geography (USD MN)
  • Metabolic & Endocrine Market Sales By Geography (USD MN)
  • Ophthalmology Market Sales By Geography (USD MN)
  • Autoimmune / Inflammatory Conditions Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Medical Device Companies Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global In Vivo CRO Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of In Vivo CRO Report
  • Market Research Process
  • Market Research Methodology
  • Global In Vivo CRO Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Animal Model
  • Market Attractiveness Analysis By Service
  • Market Attractiveness Analysis By Drug Type
  • Market Attractiveness Analysis By Therapeutic Area
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Animal Model (USD MN)
  • Rodent-Based (Rat Models, Mice Models, Other Rodent Models) Market Sales By Geography (USD MN)
  • Non-Rodent-Based Market Sales By Geography (USD MN)
  • Global Market Analysis By Service (USD MN)
  • Bioanalysis & DMPK Studies Market Sales By Geography (USD MN)
  • Toxicity Studies (GLP Toxicology Studies, Non-GLP Toxicology Studies) Market Sales By Geography (USD MN)
  • Other Services Market Sales By Geography (USD MN)
  • Global Market Analysis By Drug Type (USD MN)
  • Small-Molecule Drugs Market Sales By Geography (USD MN)
  • Large-Molecule Drugs (Cell & Gene Therapy, RNA Therapy, Other) Market Sales By Geography (USD MN)
  • Global Market Analysis By Therapeutic Area (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Clinical Pharmacology Market Sales By Geography (USD MN)
  • Cardiology Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Neurology Market Sales By Geography (USD MN)
  • Gastroenterology & Hepatology Market Sales By Geography (USD MN)
  • Metabolic & Endocrine Market Sales By Geography (USD MN)
  • Ophthalmology Market Sales By Geography (USD MN)
  • Autoimmune / Inflammatory Conditions Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Medical Device Companies Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.